Psomagen Inc. (950200) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Psomagen Inc. (950200:KRX), powered by AI.

Current Price
₩2,845
P/E Ratio
-18.3
Market Cap
54.7B
Sector
Healthcare
What is the Psomagen Inc. stock price forecast?

Psomagen Inc. is currently trading at ₩2,845. View real-time AI analysis on Alpha Lenz.

What is Psomagen Inc. insider trading activity?

View the latest insider trading data for Psomagen Inc. on Alpha Lenz.

What is Psomagen Inc.'s P/E ratio?

Psomagen Inc.'s P/E ratio is -18.3.

Psomagen Inc.

KRX · 950200
₩2,845+110(+4.02%)Market closedKRX regular session 09:00–15:30 KST
Ask about Psomagen Inc.'s future dividend policy...
Alpha Chat Insight

Psomagen Inc. trades at a P/E of -18.3 (undervalued) with modest ROE of -10.3%. 3Y revenue CAGR of 10.9% highlights clear growth momentum.

Ask for details

Company Overview

Psomagen Inc. is a biotechnology company that specializes in genomic and bioinformatic services. With a focus on next-generation sequencing (NGS), Psomagen provides comprehensive solutions for genetic testing, research, and personalized medicine. The company's services are particularly impactful within the healthcare, pharmaceutical, and academic research sectors, offering vital insights into genetic data that facilitate groundbreaking scientific discoveries and personalized treatment plans. Psomagen serves a global clientele with a robust portfolio of services including whole genome sequencing, exome sequencing, and RNA sequencing, each designed to advance the understanding of genetic information. Headquartered in South Korea, Psomagen Inc. plays a significant role in the biotechnology industry, leveraging its expertise in genomics to contribute to the rapidly evolving field of precision medicine. This enhances the ability to diagnose, treat, and prevent diseases based on individual genetic profiles, solidifying its importance in modern healthcare research and development.

CEO홍수
SectorHealthcare
IndustryDiagnostics & Research
Employees96

Company Statistics

FY 2025

Profile

₩54,726,570,785Market Cap
₩59,191,856,000Revenue
19.24MShares Out
96Employees

Margins

24.48%Gross
4.91%EBITDA
-3.81%Operating
-6.97%Pre-Tax
-6.98%Net

Valuation

-18.35P/E
2.01P/B
0.92EV/Sales
19.95EV/EBITDA
-813.73P/FCF

Growth (CAGR)

10.92%Rev 3Yr
25.51%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-7.86%ROA
-10.28%ROE
-5.98%ROIC

Financial Health

₩8,356,074,000Cash & Cash Equivalents
₩15,711,305,000Net Debt
93.59%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Psomagen Inc. (ticker: 950200) is a company listed on KRX in the Healthcare sector (Diagnostics & Research). It has approximately 96 employees. Market cap is $54.7B.

The current price is ₩2,845 with a P/E ratio of -18.35x and P/B of 2.01x.

ROE is -10.28% and operating margin is -3.81%. Annual revenue is $59.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Psomagen Inc. (950200) Stock Forecast 2026 ₩2,845 — Price, Financials & Analyst Targets | Alpha Lenz